Bayer Pharmaceuticals
Recent News About Bayer Pharmaceuticals
-
Johnson & Johnson, Bayer win second trial over Xarelto bleeding risks
&&&A federal jury in New Orleans has cleared Johnson & Johnson and Bayer AG in the second of at least 18,600 suits filed against the pharmaceutical giants stemming from the manufacturing of the blood-thinning drug Xarelto. -
.jpg)
Johnson & Johnson, Bayer prevail in first of 18,000 Xarelto trials
After emerging victorious in the first of more than 18,000 suits filed against them, Xarelto maker Johnson & Johnson and Bayer Pharmaceuticals are vowing to remain as vigilant as ever in defending their reputations.